Cargando…
Inter-observer variability of (90)Y PET/CT dosimetry in hepatocellular carcinoma after glass microspheres transarterial radioembolization
INTRODUCTION: Strong correlation has been demonstrated between tumor dose and response and between healthy liver dose and side effects. Individualized dosimetry is increasingly recommended in the current clinical routine. However, hepatic and tumor segmentations could be complex in some cases. The a...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218042/ https://www.ncbi.nlm.nih.gov/pubmed/32399636 http://dx.doi.org/10.1186/s40658-020-00302-1 |
_version_ | 1783532713555263488 |
---|---|
author | Meyers, Nicolas Jadoul, Alexandre Bernard, Claire Delwaide, Jean Lamproye, Anne Detry, Olivier Honoré, Pierre Gerard, Laurent Hustinx, Roland |
author_facet | Meyers, Nicolas Jadoul, Alexandre Bernard, Claire Delwaide, Jean Lamproye, Anne Detry, Olivier Honoré, Pierre Gerard, Laurent Hustinx, Roland |
author_sort | Meyers, Nicolas |
collection | PubMed |
description | INTRODUCTION: Strong correlation has been demonstrated between tumor dose and response and between healthy liver dose and side effects. Individualized dosimetry is increasingly recommended in the current clinical routine. However, hepatic and tumor segmentations could be complex in some cases. The aim of this study is to assess the reproducibility of the tumoral and non-tumoral liver dosimetry in selective internal radiation therapy (SIRT). MATERIAL AND METHODS: Twenty-three patients with hepatocellular carcinoma (HCC) who underwent SIRT with glass microspheres were retrospectively included in the study. Tumor (TV) and total liver volumes (TLV), and mean absorbed doses in tumoral liver (TD) and non-tumoral liver (THLD) were determined on the (90)Y PET/CT studies using Simplicit90YTM software, by three independent observers. Dosimetry datasets were obtained by a medical physicist helped by a nuclear medicine (NM) physician with 10 years of experience (A), by a NM physician with 4-year experience (B), and by a resident who first performed 10 dosimetry assessments as a training (C). Inter-observer agreement was evaluated using intra-class correlation coefficients (ICC), coefficients of variation (CV), Bland-Altman plots, and reproducibility coefficient (RDC). RESULTS: A strong agreement was observed between all three readers for estimating TLV (ICC 0.98) and THLD (ICC 0.97). Agreement was lower for TV delineation (ICC 0.94) and particularly for TD (ICC 0.73), especially for the highest values. Regarding TD, the CV (%) was 26.5, 26.9, and 20.2 between observers A and B, A and C, and B and C, respectively, and the RDC was 1.5. Regarding THLD, it was 8.5, 12.7, and 9.4, and the RDC was 1.3. CONCLUSION: Using a standardized methodology, and regardless of the different experiences of the observers, the estimation of THLD is highly reproducible. Although the reproducibility of the assessment of tumor irradiation is overall quite high, large variations may be observed in a limited number of patients. |
format | Online Article Text |
id | pubmed-7218042 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-72180422020-05-15 Inter-observer variability of (90)Y PET/CT dosimetry in hepatocellular carcinoma after glass microspheres transarterial radioembolization Meyers, Nicolas Jadoul, Alexandre Bernard, Claire Delwaide, Jean Lamproye, Anne Detry, Olivier Honoré, Pierre Gerard, Laurent Hustinx, Roland EJNMMI Phys Original Research INTRODUCTION: Strong correlation has been demonstrated between tumor dose and response and between healthy liver dose and side effects. Individualized dosimetry is increasingly recommended in the current clinical routine. However, hepatic and tumor segmentations could be complex in some cases. The aim of this study is to assess the reproducibility of the tumoral and non-tumoral liver dosimetry in selective internal radiation therapy (SIRT). MATERIAL AND METHODS: Twenty-three patients with hepatocellular carcinoma (HCC) who underwent SIRT with glass microspheres were retrospectively included in the study. Tumor (TV) and total liver volumes (TLV), and mean absorbed doses in tumoral liver (TD) and non-tumoral liver (THLD) were determined on the (90)Y PET/CT studies using Simplicit90YTM software, by three independent observers. Dosimetry datasets were obtained by a medical physicist helped by a nuclear medicine (NM) physician with 10 years of experience (A), by a NM physician with 4-year experience (B), and by a resident who first performed 10 dosimetry assessments as a training (C). Inter-observer agreement was evaluated using intra-class correlation coefficients (ICC), coefficients of variation (CV), Bland-Altman plots, and reproducibility coefficient (RDC). RESULTS: A strong agreement was observed between all three readers for estimating TLV (ICC 0.98) and THLD (ICC 0.97). Agreement was lower for TV delineation (ICC 0.94) and particularly for TD (ICC 0.73), especially for the highest values. Regarding TD, the CV (%) was 26.5, 26.9, and 20.2 between observers A and B, A and C, and B and C, respectively, and the RDC was 1.5. Regarding THLD, it was 8.5, 12.7, and 9.4, and the RDC was 1.3. CONCLUSION: Using a standardized methodology, and regardless of the different experiences of the observers, the estimation of THLD is highly reproducible. Although the reproducibility of the assessment of tumor irradiation is overall quite high, large variations may be observed in a limited number of patients. Springer International Publishing 2020-05-12 /pmc/articles/PMC7218042/ /pubmed/32399636 http://dx.doi.org/10.1186/s40658-020-00302-1 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Original Research Meyers, Nicolas Jadoul, Alexandre Bernard, Claire Delwaide, Jean Lamproye, Anne Detry, Olivier Honoré, Pierre Gerard, Laurent Hustinx, Roland Inter-observer variability of (90)Y PET/CT dosimetry in hepatocellular carcinoma after glass microspheres transarterial radioembolization |
title | Inter-observer variability of (90)Y PET/CT dosimetry in hepatocellular carcinoma after glass microspheres transarterial radioembolization |
title_full | Inter-observer variability of (90)Y PET/CT dosimetry in hepatocellular carcinoma after glass microspheres transarterial radioembolization |
title_fullStr | Inter-observer variability of (90)Y PET/CT dosimetry in hepatocellular carcinoma after glass microspheres transarterial radioembolization |
title_full_unstemmed | Inter-observer variability of (90)Y PET/CT dosimetry in hepatocellular carcinoma after glass microspheres transarterial radioembolization |
title_short | Inter-observer variability of (90)Y PET/CT dosimetry in hepatocellular carcinoma after glass microspheres transarterial radioembolization |
title_sort | inter-observer variability of (90)y pet/ct dosimetry in hepatocellular carcinoma after glass microspheres transarterial radioembolization |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218042/ https://www.ncbi.nlm.nih.gov/pubmed/32399636 http://dx.doi.org/10.1186/s40658-020-00302-1 |
work_keys_str_mv | AT meyersnicolas interobservervariabilityof90ypetctdosimetryinhepatocellularcarcinomaafterglassmicrospherestransarterialradioembolization AT jadoulalexandre interobservervariabilityof90ypetctdosimetryinhepatocellularcarcinomaafterglassmicrospherestransarterialradioembolization AT bernardclaire interobservervariabilityof90ypetctdosimetryinhepatocellularcarcinomaafterglassmicrospherestransarterialradioembolization AT delwaidejean interobservervariabilityof90ypetctdosimetryinhepatocellularcarcinomaafterglassmicrospherestransarterialradioembolization AT lamproyeanne interobservervariabilityof90ypetctdosimetryinhepatocellularcarcinomaafterglassmicrospherestransarterialradioembolization AT detryolivier interobservervariabilityof90ypetctdosimetryinhepatocellularcarcinomaafterglassmicrospherestransarterialradioembolization AT honorepierre interobservervariabilityof90ypetctdosimetryinhepatocellularcarcinomaafterglassmicrospherestransarterialradioembolization AT gerardlaurent interobservervariabilityof90ypetctdosimetryinhepatocellularcarcinomaafterglassmicrospherestransarterialradioembolization AT hustinxroland interobservervariabilityof90ypetctdosimetryinhepatocellularcarcinomaafterglassmicrospherestransarterialradioembolization |